Switch maintenance using UFT/LV therapy after Oxaliplatin based adjuvant chemotherapy for StageIII colorectal cancer

Switch maintenance using UFT/LV therapy after Oxaliplatin based adjuvant chemotherapy for StageIII colorectal cancer - FUTURE1202(SWIM III)

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009325

Enrollment

Registered

2012-11-13

Start date

2012-11-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

StageIII patients with curative resection for colorectal cancer

Interventions

Within 8 weeks after Oxaliplatin based chemotherapy (UFT/LV switch maintenance:5 course) UFT/LV p.o(4 weeks on,1week off ) to be repeated every 5 weeks.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with curative resection for stageIII colorectal cancer. 2. Patients recieved Oxaliplatin based chemotherapy as a prior therapy. 3. Possible patients using UFT/LV maintenance therapy. 4. Age:20years to 80years 5. Performance Status:0-1 6. Patients sighed informed consent 7. Vital organ functions are preserved within 14days prior to entry

Exclusion criteria

Exclusion criteria: 1.Prior severe drug allergy 2.Nursing or pregnant females, or females or mailes with partners who are planning pregnancy 3.Presence of active infection 4.Serious complications 5.Inadequate cases for study enrollment by the physician

Design outcomes

Primary

Measure	Time frame
The complete rate of treatment, Safety	—

Secondary

Measure	Time frame
3year disease free survival time	—

Countries

Japan

Contacts

Public ContactYoichiro Yoshida

Fukuoka University Faculty of Medicine Department of Gastroenterological Surgery

yyoshida@fukuoka-u.ac.jp0928011011

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026